Pharmarise Holdings Corporation

Investment timing: 2018/11
Deal type: Business Succession
Fund: AG II
Status: Exit

Investment Background

Pharmarise Holdings is a publicly listed company that operates dispensing pharmacies and drugstores in Japan. While market needs are increasing due to the growing number of elderly people, the dispensing pharmacy business environment is expected to undergo major changes in the future due to factors, such as the revision of medical fees and drug prices from the perspective of reducing national healthcare costs and the decline in the unit price of prescriptions due to the promotion of the use of generic drugs. Aspirant Group has invested to build a foundation for growth in the dispensing pharmacy business, strengthen the retail business, and reduce costs/enhance profitability working together with the company’s management team.

Post-Investment Activities

Development of Infrastructure

• Development of an accounting management system
• Design/management of meeting structure (Strengthening of group governance by establishing/operating group-wide meetings)
• Development of Corporate Infrastructure (Centralization of organizational management through integration of group companies)

Rationalization

• Reallocation of Management Resources (Scrap-and-build of pharmacies/stores)
• Improvement in Productivity – Cost reductions (Improving operational efficiency of headquarters/pharmacies/stores through company-wide centralization of systems/procurement, etc.)

Support for Growth

• Sales Support/Sales Channel Expansion, etc. (Strengthening of home care/ dispensing at facilities)
• Add-On Acquisition (M&A of peers)